Patents by Inventor Autumn Flynn

Autumn Flynn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modulators of Liver Receptor Homologue 1 (LRH-1) and Uses
    Publication number: 20230295070
    Abstract: This disclosure relates to modulators of liver receptor homologue 1 (LRH-1) and methods of managing disease and conditions related thereto. In certain embodiments, modulators are derivatives of hexahydropentalene. In certain embodiments, this disclosure relates to methods of treating or preventing cancer, diabetes, or cardiovascular disease by administering an effective amount of a hexahydropentalene derivative disclosed herein.
    Type: Application
    Filed: May 22, 2023
    Publication date: September 21, 2023
    Inventors: Eric Ortlund, Suzanne Mays, Nathan Jui, Autumn Flynn, Michael Dugan
  • Modulators of liver receptor homologue 1 (LRH-1) and uses
    Patent number: 11691939
    Abstract: This disclosure relates to modulators of liver receptor homologue 1 (LRH-1) and methods of managing disease and conditions related thereto. In certain embodiments, modulators are derivatives of hexahydropentalene. In certain embodiments, this disclosure relates to methods of treating or preventing cancer, diabetes, or cardiovascular disease by administering an effective amount of a hexahydropentalene derivative disclosed herein.
    Type: Grant
    Filed: October 15, 2020
    Date of Patent: July 4, 2023
    Assignee: Emory University
    Inventors: Eric Ortlund, Suzanne Mays, Nathan Jui, Autumn Flynn, Michael Dugan
  • Modulators of Liver Receptor Homologue 1 (LRH-1) and Uses
    Publication number: 20210047258
    Abstract: This disclosure relates to modulators of liver receptor homologue 1 (LRH-1) and methods of managing disease and conditions related thereto. In certain embodiments, modulators are derivatives of hexahydropentalene. In certain embodiments, this disclosure relates to methods of treating or preventing cancer, diabetes, or cardiovascular disease by administering an effective amount of a hexahydropentalene derivative disclosed herein.
    Type: Application
    Filed: October 15, 2020
    Publication date: February 18, 2021
    Inventors: Eric Ortlund, Suzanne Mays, Nathan Jui, Autumn Flynn, Michael Dugan
  • Modulators of liver receptor homologue 1 (LRH-1) and uses
    Patent number: 10843996
    Abstract: This disclosure relates to modulators of liver receptor homologue 1 (LRH-1) and methods of managing disease and conditions related thereto. In certain embodiments, modulators are derivatives of hexahydropentalene. In certain embodiments, this disclosure relates to methods of treating or preventing cancer, diabetes, or cardiovascular disease by administering an effective amount of a hexahydropentalene derivative disclosed herein.
    Type: Grant
    Filed: March 16, 2018
    Date of Patent: November 24, 2020
    Assignee: Emory University
    Inventors: Eric Ortlund, Suzanne Mays, Nathan Jui, Autumn Flynn, Michael Dugan
  • Modulators of Liver Receptor Homologue 1 (LRH-1) and Uses
    Publication number: 20200017433
    Abstract: This disclosure relates to modulators of liver receptor homologue 1 (LRH-1) and methods of managing disease and conditions related thereto. In certain embodiments, modulators are derivatives of hexahydropentalene. In certain embodiments, this disclosure relates to methods of treating or preventing cancer, diabetes, or cardiovascular disease by administering an effective amount of a hexahydropentalene derivative disclosed herein.
    Type: Application
    Filed: March 16, 2018
    Publication date: January 16, 2020
    Applicant: Emory University
    Inventors: Eric Ortlund, Suzanne Mays, Nathan Jui, Autumn Flynn, Michael Dugan